Sylvain Simon

6PUBLICATIONS
76CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 11, 2025
Gut Microbiota Modulation through Akkermansia spp. Supplementation Increases CAR T-cell Potency.

Laura Marcos-Kovandzic, Michele Avagliano, Myriam Ben Khelil

|Mar 18, 2025
Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapy.

Sylvain Simon, Grace Bugos, Rachel Prins

|Feb 07, 2024
Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity.

Tamer Basel Shabaneh, Andrew R Stevens, Sylvia M Stull

|Oct 18, 2021
Dual Targeting with CAR T Cells to Limit Antigen Escape in Multiple Myeloma.

Sylvain Simon, Stanley R Riddell

|Nov 14, 2020
PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy.

Sylvain Simon, Valentin Voillet, Virginie Vignard

|Aug 22, 2020
Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage.

Aurélie Fluckiger, Romain Daillère, Mohamed Sassi

Pageof 1